David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Kosmos Energy
KOS
$1.66B
| $3.42M | 0.01% |
430,162
-206,378
| -32% | -$1.43M |
|
|
SCLN
1627
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $3.42M | 0.01% |
305,279
+19,132
| +7% | +$211K |
|
1628
Banner Corp
BANR
$2.39B
| $3.42M | 0.01% |
55,723
-7,861
| -12% | -$445K |
|
1629
Iridium Communications
IRDM
$5B
| $3.42M | 0.01% |
331,517
+148,601
| +81% | +$1.54M |
|
|
DF
1630
DELISTED
Dean Foods Company
DF
| $3.41M | 0.01% |
313,520
+92,207
| +42% | +$1.19M |
|
1631
Medifast
MED
$137M
| $3.41M | 0.01% |
57,369
+4,656
| +9% | +$232K |
|
|
TTM
1632
DELISTED
Tata Motors Limited
TTM
| $3.41M | 0.01% |
+108,903
| New | +$3.5M |
|
1633
FirstEnergy
FE
$27B
| $3.4M | 0.01% |
110,322
-1,185,329
| -91% | -$37.3M |
|
1634
Omega Healthcare
OHI
$14.2B
| $3.4M | 0.01% |
106,426
-117,297
| -52% | -$3.76M |
|
1635
Foster
FSTR
$395M
| $3.39M | 0.01% |
148,801
+14,646
| +11% | +$286K |
|
|
SBNY
1636
PUT
DELISTED
Signature Bank
SBNY
| $3.38M | 0.01% |
+26,400
| New | +$3.47M |
|
|
DYNC
1637
DELISTED
Vistra Energy Corp.
DYNC
| $3.38M | 0.01% |
+50,000
| New | +$3.22M |
|
1638
Ionis Pharmaceuticals
IONS
$10.5B
| $3.38M | 0.01% |
66,568
+12,704
| +24% | +$665K |
|
1639
Williams-Sonoma
WSM
$28B
| $3.37M | 0.01% |
135,282
-16,924
| -11% | -$393K |
|
1640
Blackstone Mortgage Trust
BXMT
$2.35B
| $3.36M | 0.01% |
108,416
+46,820
| +76% | +$1.46M |
|
1641
Watts Water Technologies
WTS
$12.6B
| $3.35M | 0.01% |
48,467
-2,135
| -4% | -$137K |
|
|
CATM
1642
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $3.35M | 0.01% |
+145,626
| New | +$4.14M |
|
1643
Equinor
EQNR
$98B
| $3.35M | 0.01% |
166,727
+106,472
| +177% | +$1.97M |
|
|
KBAL
1644
DELISTED
Kimball International
KBAL
| $3.34M | 0.01% |
168,946
-6,098
| -3% | -$104K |
|
1645
PUT
Allegiant Air
ALGT
$2.26B
| $3.33M | 0.01% |
+25,300
| New | +$3.26M |
|
1646
Varex Imaging
VREX
$779M
| $3.33M | 0.01% |
98,470
+28,063
| +40% | +$878K |
|
1647
MarketAxess Holdings
MKTX
$5.72B
| $3.33M | 0.01% |
18,049
+1,088
| +6% | +$208K |
|
1648
Koppers
KOP
$876M
| $3.32M | 0.01% |
71,909
-6,266
| -8% | -$244K |
|
|
CS
1649
DELISTED
Credit Suisse Group
CS
| $3.31M | 0.01% |
+209,176
| New | +$3.18M |
|
|
EGL
1650
DELISTED
Engility Holdings, Inc.
EGL
| $3.3M | 0.01% |
95,193
-9,659
| -9% | -$294K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.